Hedge Fund and Insider Trading News: MSD Capital, Marble Ridge Capital, Citadel LLC, Third Point LLC, Broadcom Inc (AVGO), FSD Pharma Inc (HUGE), and More

Page 2 of 2

Broadcom Inc (AVGO) President and CEO Hock E Tan Sold $19.2 million of Shares (Guru Focus)
President and CEO of Broadcom Inc, Hock E Tan, sold 57,172 shares of AVGO on 08/25/2020 at an average price of $335.05 a share. The total sale was $19.2 million. Broadcom Inc is engaged in designing, developing and supplying analog and digital semiconductor connectivity solutions. Its product portfolio serves wired infrastructure, wireless communications, enterprise storage and industrial and other end markets.

How Deep Tech Investing Can Drive Consistent Performance (Preqin.com)
A focus on technology risk and being global-minded are key to investing in innovation. Managing Risk in Innovation: All VC firms look for ‘innovative’ opportunities, but we view such opportunities by identifying three associated risks: technology risk, intellectual property (IP) risk, and market risk. A company that has none of these risks is usually too mature and late stage for VC investors to consider. In this context, VC investors choose to take on any – or a combination – of these risks when making investments. In Vickers Venture’s case, we only take one risk – technology, while minimizing or avoiding our exposure to the other risk categories. Market risk, in particular, is something we look to mitigate in investment decisions because it is very difficult to predict the potential demand for any product. Whether a market even exists for a company’s product is the biggest hurdle to overcome. It is this type of high-risk bet that makes VC results so volatile.

Empty Hotels Might Just Be Next Big Short for Hedge Funds (Bloomberg)
Hedge funds and other short sellers are beginning to set their sights on a U.S. credit-derivatives index with outsized exposure to hotel debt as the pandemic sinks the hospitality industry into distress. The firms are starting to build up wagers against the synthetic index, known as CMBX 9, shifting attention from a high-profile bet against America’s challenged malls. The shift, which market participants say is beginning to show up in some trading flows, comes as delinquencies on hospitality property loans surge and even begin to exceed those in retail.

The Co-Chairman of FSD Pharma (NASDAQ: HUGE) is Buying Shares (Analyst Ratings)
Yesterday, the Co-Chairman of FSD Pharma (HUGE), Anthony John Durkacz, bought shares of HUGE for $499.6K. This recent transaction increases Anthony John Durkacz’s holding in the company by 56% to a total of $1.28 million. In addition to Anthony John Durkacz, 9 other HUGE executives reported Buy trades in the last month. The company has a one-year high of $17.49 and a one-year low of $2.39.

Thermo Fisher Scientific Inc (TMO) Executive Vice President & COO Mark Stevenson Sold $9.2 million of Shares (Guru Focus)
Executive Vice President & COO of Thermo Fisher Scientific Inc, Mark Stevenson, sold 22,000 shares of TMO on 08/25/2020 at an average price of $420.16 a share. The total sale was $9.2 million. Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.






Page 2 of 2